PRLAX | SLAPX | PRLAX / SLAPX | |
Total Expense Ratio | 1.46 | 2.18 | 67% |
Annual Report Gross Expense Ratio | 1.46 | 2.35 | 62% |
Fund Existence | 31 years | 24 years | - |
Gain YTD | 23.906 | 29.897 | 80% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 1000 | 250% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 370M | 277M | 134% |
Annual Yield % from dividends | 2.93 | 3.36 | 87% |
Returns for 1 year | 3.62 | 7.13 | 51% |
Returns for 3 years | 17.63 | 16.45 | 107% |
Returns for 5 years | 20.18 | 39.88 | 51% |
Returns for 10 years | 16.49 | 72.45 | 23% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
WSTCX | 24.48 | 0.14 | +0.58% |
Macquarie Science and Technology C | |||
MUETX | 35.82 | N/A | N/A |
MFS Blended Research Core Equity R3 | |||
WLCVX | 21.50 | N/A | N/A |
Wilshire Large Company Value Instl | |||
SMIPX | 13.32 | N/A | N/A |
Saratoga Mid Capitalization I | |||
MNBIX | 19.86 | N/A | N/A |
Manning & Napier Pro-Blend Extnd Term I |